Encabo A, Ferrer M, Marín J, Peiró C, Redondo J, de Sagarra M R, Balfagón G
Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma, Madrid, Spain.
J Pharm Pharmacol. 1993 Apr;45(4):274-9. doi: 10.1111/j.2042-7158.1993.tb05552.x.
The aim of the present study was to analyse the ability of phorbol 12,13-dibutyrate (PDB) to activate protein kinase C (PKC), measured by its capacity to translocate the enzyme from the cytosol to the membrane fraction, as well as to induce vasconstrictive responses in segments from branches of bovine cerebral arteries. PDB (0.1 microM) produced a marked translocation of PKC activity from the cytosolic to the membranous fraction. This drug induced concentration-dependent contractions which were slow in onset. The contraction elicited by PDB was reduced by the PKC inhibitor, staurosporine (1 and 10 nM), but unaltered by both Ca(2+)-free medium containing 3 mM EGTA and the Ca(2+)-channel antagonist, nifedipine (1 microM). Preincubation of segments with PDB (10 and 30 nM) reduced the vasoconstriction elicited by 5-hydroxytryptamine (5-HT) in a concentration- and preincubation time-dependent manner. These data indicate that bovine cerebral arteries possess cytosolic and membranous PKC activities, that the vasoconstrictive responses induced by PDB were independent of extracellular Ca2+, that cytosolic C-kinase is translocated to the membrane and probably down-regulated by PDB, and that this enzyme is not involved in 5-HT responses, but is down-regulated by PDB.
本研究的目的是分析佛波醇12,13 - 二丁酸酯(PDB)激活蛋白激酶C(PKC)的能力,通过其将该酶从胞质溶胶转运至膜部分的能力来衡量,同时分析其在牛脑动脉分支段诱导血管收缩反应的能力。PDB(0.1微摩尔)使PKC活性从胞质溶胶显著转运至膜部分。该药物诱导浓度依赖性收缩,起效缓慢。PKC抑制剂星形孢菌素(1和10纳摩尔)可减弱PDB引发的收缩,但含3毫摩尔乙二醇双四乙酸的无钙培养基以及钙通道拮抗剂硝苯地平(1微摩尔)对其无影响。用PDB(10和30纳摩尔)预孵育动脉段可浓度和预孵育时间依赖性地减弱5 - 羟色胺(5 - HT)引发的血管收缩。这些数据表明,牛脑动脉具有胞质溶胶和膜PKC活性,PDB诱导的血管收缩反应不依赖细胞外钙离子,胞质溶胶C激酶被转运至膜且可能被PDB下调,并且该酶不参与5 - HT反应,但被PDB下调。